ALL three-lens brief
Evidence-based stock research on ALL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · RSI at 70 — technically overbought.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- RSI at 70 — technically overbought.
- Outperforming SPY by 19.7pp over 30 days.
- P/E of 5.5 — trading at a value multiple.
ALL closed at $250.71 (+0.83%) as of 2026-07-10. Market cap: $64.54B. P/E (trailing) 5.5. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 19.7pp over 30 days.. Concerns: rSI at 70 — technically overbought.. Last quarter: Revenue $16.94B, net income $2.43B, free cash flow $12.43B.
Why three lenses on ALL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALL brief"></iframe>